FR3051320B1 - Composition detachant les oeufs de pou et les lentes - Google Patents

Composition detachant les oeufs de pou et les lentes Download PDF

Info

Publication number
FR3051320B1
FR3051320B1 FR1660214A FR1660214A FR3051320B1 FR 3051320 B1 FR3051320 B1 FR 3051320B1 FR 1660214 A FR1660214 A FR 1660214A FR 1660214 A FR1660214 A FR 1660214A FR 3051320 B1 FR3051320 B1 FR 3051320B1
Authority
FR
France
Prior art keywords
composition
weight
pou
slow
thickener
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1660214A
Other languages
English (en)
Other versions
FR3051320A1 (fr
Inventor
Nigel Cooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thornton and Ross Ltd
Original Assignee
Thornton and Ross Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thornton and Ross Ltd filed Critical Thornton and Ross Ltd
Publication of FR3051320A1 publication Critical patent/FR3051320A1/fr
Application granted granted Critical
Publication of FR3051320B1 publication Critical patent/FR3051320B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition pour faciliter le retrait des œufs de pou et des lentes des cheveux en les détachant de sorte qu'ils peuvent être retirés par coiffage, la composition comprenant un gel aqueux contenant au moins 5 % en poids d'une huile acceptable du point de vue cosmétique, un épaississant et de l'eau. De préférence, le gel aqueux comprend au moins 20 % en poids d'une huile acceptable du point de vue cosmétique, qui est avantageusement une substance quelconque parmi l'isononanoate d'isononyle et le palmitate d'isopropyle ou un mélange de telles substances, et au moins 60 % en poids d'eau. L'épaississant peut être un gel comprenant un copolymère acrylate de sodium/acryloyldiméthyltaurate de sodium et de l'isononanoate d'isononyle, et la composition a de préférence un pH de 6 à 8 et est avantageusement de pH neutre.
FR1660214A 2016-05-17 2016-10-21 Composition detachant les oeufs de pou et les lentes Active FR3051320B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1608647.2A GB2550558B (en) 2016-05-17 2016-05-17 A louse ova and nit loosening composition
GB16086472 2016-05-17

Publications (2)

Publication Number Publication Date
FR3051320A1 FR3051320A1 (fr) 2017-11-24
FR3051320B1 true FR3051320B1 (fr) 2019-05-10

Family

ID=56320527

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1660214A Active FR3051320B1 (fr) 2016-05-17 2016-10-21 Composition detachant les oeufs de pou et les lentes

Country Status (4)

Country Link
EP (1) EP3458021A1 (fr)
FR (1) FR3051320B1 (fr)
GB (1) GB2550558B (fr)
WO (1) WO2017198982A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2574022A (en) * 2018-05-22 2019-11-27 Thornton & Ross Ltd A pediculicidal shampoo

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147800A (en) * 1977-01-17 1979-04-03 Block Drug Company, Inc. Pediculicidal toxicants
US6607716B1 (en) * 1998-09-29 2003-08-19 Tech Labs, Inc. Pediculicidal compositions, a kit, and methods of use
US6524604B1 (en) * 2000-07-21 2003-02-25 Del Laboratories, Inc. Method, composition and kit to remove lice ova from the hair
FR2874503B1 (fr) * 2004-09-01 2006-11-24 Soc Ind Limousine Dapplication Biologique Silab Procede d'obtention d'un principe actif raffermissant et a visee anti-vergetures, actif obtenu et les fonctionnalites
ITRM20070441A1 (it) * 2007-08-13 2009-02-14 N B S S R L Composizioni dermocosmetiche a base di polisaccaride del seme di tamarindo ed estratti vegetali.
US20090285869A1 (en) * 2008-05-14 2009-11-19 Humco Holding Group, Inc. Salt stable lecithin organogel composition
EP2306817A1 (fr) * 2008-07-06 2011-04-13 Lice Up Ltd. Compositions de traitement anti-phthiraptère
US20140296182A1 (en) * 2011-08-29 2014-10-02 Orna Levin Method and composition for treating lice infestation
FR3025096B1 (fr) * 2014-08-28 2016-12-23 Oreal Composition gel/gel contenant un actif anti-transpirant

Also Published As

Publication number Publication date
GB2550558A (en) 2017-11-29
WO2017198982A1 (fr) 2017-11-23
EP3458021A1 (fr) 2019-03-27
FR3051320A1 (fr) 2017-11-24
GB201608647D0 (en) 2016-06-29
GB2550558B (en) 2020-06-17

Similar Documents

Publication Publication Date Title
MA35070B1 (fr) Traitements ophtalmiques
MA31862B1 (fr) Anticorps anti-mésothéline et leurs utilisations
BE901390A (fr) Nouvelles compositions cosmetiques ou dermatologiques pour les soins de la peau.
MA38194B1 (fr) Anticorps anti-ceacam5 et leurs utilisations
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
FR3053247B1 (fr) Procede cosmetique de traitement des matieres keratiniques mettant en œuvre une composition comprenant de l’acide ascorbique
FR3004939B1 (fr) Huile essentielle de satureja montana a forte teneur en geraniol, et utilisation pour traiter les peaux grasses et/ou les defauts esthetiques associes
FR3076725B1 (fr) Shampoings colorants améliorés
FR3051320B1 (fr) Composition detachant les oeufs de pou et les lentes
MA29508B1 (fr) Compositions détergentes sous forme de microémulsions et leur utilisation dans le traitement de l'alopécie
EP0279136A3 (fr) Cosmétique pour retarder le vieillissement de la peau et procédé d'application
FR3104025B1 (fr) Nouvelles compositions cosmétiques
FR3090376B1 (fr) Extrait aqueux de fruits de Rose comme agent neuro-protecteur cutané
MA54276B1 (fr) Montélukast destinée au traitement de l'arthrose de la main
FR3076219B1 (fr) Composition cosmetique sous forme de nanoemulsion huile-dans-eau comprenant au moins 40 % de corps gras, au moins un tensioactif cationique et de l'eau
FR3057778B1 (fr) Nouvelles compositions actives sur les adipocytes
FR3070266B1 (fr) Melange d'huile pour microemulsion
MA51831B1 (fr) Composition pour la prévention et le traitement de troubles de la pousse des cheveux
FR3098713B1 (fr) Nanoparticules d’or comprenant un extrait de plantes et leur utilisation cosmetique
FR3083109B1 (fr) Procede de traitement des matieres keratiniques par des composes c-glycosides5-oxazolidine-2,4-diones, composes et composition cosmetique les contenant
FR3089974B1 (fr) Nouveaux composés dépigmentants extraits de Eryngium maritimum
BE1000724A6 (fr) Compositions a base de dithranol.
FR3115990B1 (fr) Composition comprenant au moins un polysaccharide de graines de tamarin indica
FR3097742B1 (fr) Bactérie de la famille desChristensenellacéeset composition en contenant pour la prévention et/ou le traitement de l’insuffisance rénale.
FR3075609B1 (fr) Compositions comprenant de l’acide salicylique ou l’un de ses derives, un tensioactif possedant un hlb superieur ou egal a 9,7, et au moins un polymere epaississant

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

EXTE Extension to a french territory

Extension state: PF

PLFP Fee payment

Year of fee payment: 3

PLSC Publication of the preliminary search report

Effective date: 20181026

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8